In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandins.

The effects of prostaglandins (PGs) on the Cloudman S91 melanoma CCL 53.1 cell line indicate that melanogenesis and proliferation are regulated by separate mechanisms that are not necessarily cyclic AMP (cAMP) dependent. These cells responded to PGE1 and PGE2 in a dose-dependent manner, by an increase of tyrosinase activity and by inhibition of proliferation. PGA1 and PGD2 inhibited cellular proliferation and tyrosinase activity, while PGF2 alpha had no effect after 24 h of treatment. PGE1, but not PGE2 or PGD2, increased cellular cAMP levels after 30 min of treatment. Treatment with 10 micrograms/ml PGE1 inhibited cellular proliferation after 4 h and enhanced tyrosinase activity after 12 h. Tyrosinase stimulation by PGE1 required de novo transcription and translation. Actinomycin D, cycloheximide, and the tyrosinase inhibitor phenylthiocarbamide blocked tyrosinase activation but did not alter the inhibitory effect of PGE1 on proliferation. Dibutyryl cAMP and 3-isobutyl-1-methylxanthine augmented tyrosinase activation by PGE1 without enhancing the inhibitory action of PGE1 on cell growth. Neither blockage nor enhancement of the PGE1 effect on tyrosinase altered the PGE1-induced retardation of proliferation. These results are in marked contrast to the traditional concept that elevation of cAMP levels in melanoma cells necessarily results in stimulation of melanogenesis and inhibition of proliferation. The data presented propose independent and possibly alternative pathways for the regulation of these two cellular events.

[1]  K. Kato,et al.  Inhibition of human ovarian cancer cell growth in vitro and in nude mice by prostaglandin D2. , 1986, Cancer research.

[2]  C. Funk,et al.  Inhibition of human melanoma growth by prostaglandin A, D, and J analogues. , 1986, Cancer research.

[3]  E. G. Adams,et al.  Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture. , 1986, Cancer research.

[4]  F. Meyskens,et al.  Anchorage-independent growth of murine melanoma in serum-less media is dependent on insulin or melanocyte-stimulating hormone. , 1985, Experimental cell research.

[5]  T. Kuroki,et al.  Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. , 1985, Cancer research.

[6]  S. Narumiya,et al.  delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition. , 1985, Biochemical and biophysical research communications.

[7]  S. Narumiya,et al.  9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[8]  F. Meyskens,et al.  Inhibition of human malignant melanoma colony-forming cells in vitro by prostaglandin A1. , 1983, Cancer research.

[9]  K. Honn,et al.  Prostaglandin Analogs as Inhibitors of Tumor Cell DNA Synthesis 1 , 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[10]  R. Lotan,et al.  Enhancement of melanotic expression in cultured mouse smelanoma cells by retinoids , 1981, Journal of cellular physiology.

[11]  D. Viskochil,et al.  The role of RNA and protein synthesis in mediating the action of MSH on mouse melanoma cells. , 1979, Life sciences.

[12]  J. Pawelek,et al.  5,6-Dihydroxyindole is a melanin precursor showing potent cytotoxicity , 1978, Nature.

[13]  J. Mcguire,et al.  Dibutyryl cyclic AMP arrests the growth of cultivated cloudman melanoma cells in the late S and G2 phases of the cell cycle , 1977, Journal of cellular physiology.

[14]  R. Halaban,et al.  The dual effect of melanocyte-stimulating hormone (MSH) on the growth of cultured mouse melanoma cells. , 1977, Experimental cell research.

[15]  B. Jaffe,et al.  Inhibition of tumour growth in vivo and in vitro by prostaglandin E , 1976, Nature.

[16]  J. Pawelek,et al.  Factors regulating growth and pigmentation of melanoma cells. , 1976, The Journal of investigative dermatology.

[17]  W. Ward,et al.  Effects of adenosine nucleosides on adenylate cyclase, phosphodiesterase, cyclic adenosine monophosphate accumulation, and lipolysis in fat cells. , 1972, The Journal of biological chemistry.

[18]  S. Pomerantz L-Tyrosine-3, 5-3H Assay for Tyrosinase Development in Skin of Newborn Hamsters , 1969, Science.

[19]  S. Pomerantz,et al.  Tyrosine hydroxylation catalyzed by mammalian tyrosinase: an improved method of assay. , 1964, Biochemical and biophysical research communications.

[20]  V. Hruby,et al.  Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins. , 1985, Molecular and Cellular Endocrinology.

[21]  T. Simmet,et al.  Inhibition of B-16 melanoma growth in vitro by prostaglandin D2. , 1983, Prostaglandins.